OrthoPediatrics Corp. (NASDAQ:KIDS) Shares Acquired by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP grew its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 29.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 671,968 shares of the company’s stock after purchasing an additional 152,681 shares during the quarter. Dimensional Fund Advisors LP’s holdings in OrthoPediatrics were worth $15,576,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in KIDS. R Squared Ltd acquired a new stake in OrthoPediatrics during the 4th quarter worth $48,000. KLP Kapitalforvaltning AS purchased a new position in shares of OrthoPediatrics during the fourth quarter worth about $79,000. AlphaCentric Advisors LLC acquired a new stake in shares of OrthoPediatrics during the fourth quarter worth about $171,000. Wells Fargo & Company MN lifted its holdings in shares of OrthoPediatrics by 31.1% in the 4th quarter. Wells Fargo & Company MN now owns 9,853 shares of the company’s stock valued at $228,000 after purchasing an additional 2,338 shares during the last quarter. Finally, HighTower Advisors LLC acquired a new stake in shares of OrthoPediatrics in the 4th quarter valued at about $268,000. Institutional investors and hedge funds own 69.05% of the company’s stock.

OrthoPediatrics Stock Up 4.1 %

Shares of OrthoPediatrics stock opened at $23.08 on Friday. OrthoPediatrics Corp. has a one year low of $20.25 and a one year high of $35.99. The company has a market cap of $560.54 million, a P/E ratio of -18.76 and a beta of 1.09. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. The firm has a fifty day moving average of $23.09 and a two-hundred day moving average of $24.12.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings data on Wednesday, May 7th. The company reported ($0.39) EPS for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.13). OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. The firm had revenue of $52.41 million during the quarter, compared to analyst estimates of $51.68 million. On average, analysts forecast that OrthoPediatrics Corp. will post -0.93 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on KIDS. Piper Sandler reduced their price objective on OrthoPediatrics from $40.00 to $30.00 and set an “overweight” rating for the company in a research note on Thursday. Stifel Nicolaus reduced their price target on shares of OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating for the company in a research report on Wednesday, March 5th. Needham & Company LLC reissued a “buy” rating and set a $42.00 price objective on shares of OrthoPediatrics in a research report on Thursday. Truist Financial dropped their price objective on shares of OrthoPediatrics from $26.00 to $24.00 and set a “hold” rating on the stock in a research note on Friday, April 11th. Finally, Lake Street Capital began coverage on shares of OrthoPediatrics in a research note on Monday, April 7th. They set a “buy” rating and a $37.00 target price for the company. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $35.83.

Insider Activity at OrthoPediatrics

In other news, CEO David R. Bailey sold 6,620 shares of OrthoPediatrics stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $24.86, for a total transaction of $164,573.20. Following the completion of the sale, the chief executive officer now directly owns 319,155 shares in the company, valued at approximately $7,934,193.30. This trade represents a 2.03 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Gregory A. Odle sold 5,359 shares of the company’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $133,224.74. Following the completion of the sale, the insider now owns 148,788 shares in the company, valued at approximately $3,698,869.68. This represents a 3.48 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 23,732 shares of company stock worth $589,978 over the last three months. 32.70% of the stock is currently owned by corporate insiders.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.